Concepedia
Statistics
Publications
4
Citations
88
H-Index
Active since
1992
Affiliations
Peking University(Current)
Peking University First Hospital
Capital Medical University
Beijing Shijitan Hospital
Jisong Li is an author at Peking University specializing in medicine, oncology, and metastatic signaling pathways.
Publications per year
1992–2022
BRM transcriptionally regulates miR-302a-3p to target SOCS5/STAT3 signaling axis to potentiate pancreatic cancer metastasis
Zhengkui Zhang, Jisong Li, Huahu Guo et al. · Cancer Letters · 2019 · 32 citations
Medicine, Molecular Biology, Oncology +12
4-pregnene-3-one-20β-carboxaldehyde: A potent inhibitor of 17α-hydroxylase/C17,20-lyase and of 5α-reductase
Jisong Li, Yan Li, Chong Son et al. · The Journal of Steroid Biochemistry and Molecular Biology · 1992 · 27 citations
Life Sciences, Medicinal Chemistry, Pharmacology +10
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Mingzhe Li, Jiaxin Zhou, Zhengkui Zhang et al. · Chinese Medical Journal · 2022 · 19 citations · Full text
Medicine, Cell Biology, Oncology +17
Prognostic factors for disease-free survival in patients with pancreatic ductal adenocarcinoma after surgery: a single center experience
Xiaodong Tian, Jisong Li, Hongqiao Gao et al. · Journal of Pancreatology · 2019 · 10 citations · Full text
Medicine, Oncology, Surgery +16
1–4 of 4